Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023

医療向け分析検査サービスの世界市場予測(~2023年):種類、エンドユーザー、地域別分析

◆タイトル:Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023
◆商品コード:AST-4341
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年3月20日
◆ページ数:298
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、医療向け分析検査サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、需要先別分析、地域別分析、医療向け分析検査サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The global healthcare analytical testing services market projected to grow at a CAGR of 11.7%.”The healthcare analytical testing services market is expected to reach USD 5.97 billion by 2023 from an estimated USD 3.43 billion in 2018, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the healthcare analytical testing services market. However, factors such as the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry are limiting the adoption of healthcare analytical testing services up to some extent during the forecast period.

“The batch-release testing segment is expected to register the highest CAGR during the forecast period.”
On the basis of type, the healthcare analytical testing services market is segmented into bioanalytical testing, physical characterization, method development and validation, raw material testing, stability testing, batch release testing, microbial testing, and environmental monitoring. The batch-release testing segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is mainly due to the stringent regulations that require batch-release testing to be conducted for products marketed. In addition, the growing generic pharmaceuticals industry is further expected to drive the growth of this market.

“Pharmaceutical & biopharmaceutical companies segment expected to grow at the highest CAGR during 2018 to 2023.”
Based on end user, the healthcare analytical testing services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies and contract research organizations. The pharmaceutical & biopharmaceutical companies segment is the fastest-growing end-user segment in the healthcare analytical testing services market during the forecast period. The growing pressure on drug manufacturers to deliver high-quality products and increasing outsourcing of analytical testing services are the major factors driving the growth of the healthcare analytical testing services market for pharmaceutical & biopharmaceutical companies.

“APAC is projected to witness the highest growth during the forecast period.”
North America held the largest share of the global healthcare analytical testing services market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, due to the increasing R&D funding, growing number of CROs, and favorable government initiatives to promote pharmaceutical and biopharmaceutical industries in several APAC countries.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–28%, Tier 2–43% and Tier 3–29%
• By Designation – C-level–14%, Director Level–43%, Others–43%
• By Region – North America–43%, Europe–14%, Asia Pacific–29%, Rest of World–14%

The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), Charles River Laboratories (US), Almac Group (UK), Exova Group (UK), PPD (US), Source BioScience (UK), Anabiotec (Belgium), Intertek Group (UK), Wuxi PharmaTech (China), and BioReliance (US).
Research Coverage:
The report analyzes the various healthcare analytical testing services and their adoption pattern. It aims at estimating the market size and future growth potential of the global healthcare analytical testing services market for different segments such as by type, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global healthcare analytical testing services market. The report analyzes the global healthcare analytical testing services market by type, end user, and region
• Service Development/Innovation: Detailed insights on upcoming trends and service launches in the global healthcare analytical testing services market
• Market Development: Comprehensive information on the lucrative emerging regions by type, end user, and region
• Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the global healthcare analytical testing services market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and services of leading players in the global healthcare analytical testing services market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.4 YEARS CONSIDERED FOR THE STUDY 24
1.5 CURRENCY 25
1.6 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 29
2.1.2.1 Key data from primary sources 29
2.1.2.2 Breakdown of primary 29
2.1.2.3 Key industry insights 30
2.2 MARKET SIZE ESTIMATION 30
2.2.1 BOTTOM-UP APPROACH 31
2.2.2 TOP-DOWN APPROACH 31
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.4 ASSUMPTIONS FOR THE STUDY 33
2.5 LIMITATIONS 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 38
4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW 38
4.2 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER & COUNTRY 39
4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL SNAPSHOT 40
4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL MIX 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Focus on analytical testing of biologics and biosimilars 43
5.2.1.2 Increasing preference for outsourcing analytical testing 44
5.2.1.3 Rising adoption of the Quality by Design approach 44
5.2.1.4 Adoption of FTE contracts in R&D outsourcing 45
5.2.2 RESTRAINTS 45
5.2.2.1 Pricing pressure faced by major players 45
5.2.2.2 Shortage of skilled professionals 46
5.2.3 OPPORTUNITIES 46
5.2.3.1 Rising demand for specialized analytical testing services 46
5.2.3.2 Growth opportunities in emerging Asia Pacific countries 46
5.2.4 CHALLENGES 47
5.2.4.1 Innovative formulations and medical devices demanding a unique analytical testing approach 47
5.2.4.2 Development of appropriate dissolution methods 47
5.2.4.3 Growing need to improve the sensitivity of analytical methods 48
6 INDUSTRY INSIGHTS 49
6.1 INDUSTRY TRENDS 49
6.1.1 GROWING INDUSTRY CONSOLIDATION 49
6.1.2 LONG-TERM OUTSOURCING AND PREFERRED VENDOR PARTNERSHIPS 50
6.2 REGULATORY ANALYSIS 51
7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE 54
7.1 INTRODUCTION 55
7.2 BIOANALYTICAL TESTING 57
7.2.1 CELL-BASED ASSAYS 59
7.2.2 VIROLOGY TESTING 60
7.2.2.1 In vitro assays 61
7.2.2.2 In vivo assays 62
7.2.2.3 Species-specific viral PCR assays 63
7.2.3 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING 64
7.2.4 BIOMARKER TESTING 65
7.2.5 PHARMACOKINETIC TESTING 66
7.3 PHYSICAL CHARACTERIZATION 68
7.3.1 LASER PARTICLE SIZE ANALYSIS 70
7.3.2 THERMAL ANALYSIS 71
7.3.3 IMAGE ANALYSIS 72
7.3.4 SURFACE AREA ANALYSIS 73
7.3.5 OTHER PHYSICAL CHARACTERIZATION ANALYSIS SERVICES 74
7.4 METHOD DEVELOPMENT & VALIDATION 75
7.4.1 EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT & VALIDATION 77
7.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION 78
7.4.3 STABILITY INDICATING METHOD VALIDATION 79
7.4.4 CLEANING VALIDATION METHOD DEVELOPMENT 80
7.4.5 ANALYTICAL STANDARD CHARACTERIZATION 81
7.4.6 TECHNICAL CONSULTING 82
7.4.7 OTHER METHOD VALIDATION SERVICES 83
7.5 RAW MATERIAL TESTING 84
7.5.1 COMPLETE COMPENDIAL TESTING 86
7.5.2 HEAVY METAL TESTING 87
7.5.3 CONTAINER TESTING 88
7.5.4 KARL FISCHER ANALYSIS 90
7.5.5 WET CHEMISTRY ANALYSIS 91
7.5.6 OTHER RAW MATERIAL TESTING SERVICES 92
7.6 BATCH-RELEASE TESTING 93
7.6.1 DISSOLUTION TESTING 95
7.6.2 ELEMENTAL IMPURITY TESTING 96
7.6.3 DISINTEGRATION TESTING 98
7.6.4 HARDNESS TESTING 100
7.6.5 FRIABILITY TESTING 101
7.6.6 OTHER BATCH-RELEASE TESTING SERVICES 101
7.7 STABILITY TESTING 102
7.7.1 DRUG SUBSTANCE STABILITY TESTING 104
7.7.2 FORMULATION EVALUATION STABILITY TESTING 105
7.7.3 ACCELERATED STABILITY TESTING 106
7.7.4 PHOTOSTABILITY TESTING 107
7.7.5 COMPARATIVE STABILITY TESTING 108
7.7.6 OTHER STABILITY TESTING SERVICES 109
7.8 MICROBIAL TESTING 110
7.8.1 MICROBIAL LIMIT TESTING 112
7.8.2 STERILITY TESTING 113
7.8.3 ENDOTOXIN TESTING 114
7.8.4 PRESERVATIVE EFFICACY TESTING 115
7.8.5 WATER TESTING 116
7.8.6 OTHER MICROBIAL TESTING SERVICES 117
7.9 ENVIRONMENTAL MONITORING 118
7.9.1 AIR TESTING 120
7.9.2 WASTEWATER/ETP TESTING 121
7.9.3 OTHER ENVIRONMENTAL MONITORING SERVICES 123
8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER 124
8.1 INTRODUCTION 125
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 126
8.3 MEDICAL DEVICE COMPANIES 128
8.4 CONTRACT RESEARCH ORGANIZATIONS 130

9 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION 131
9.1 INTRODUCTION 132
9.2 NORTH AMERICA 133
9.2.1 US 140
9.2.2 CANADA 147
9.3 EUROPE 152
9.3.1 GERMANY 160
9.3.2 UK 167
9.3.3 FRANCE 173
9.3.4 ITALY 178
9.3.5 SWITZERLAND 184
9.3.6 REST OF EUROPE 189
9.4 ASIA PACIFIC 196
9.4.1 CHINA 202
9.4.2 JAPAN 207
9.4.3 INDIA 213
9.4.4 REST OF ASIA PACIFIC 219
9.5 LATIN AMERICA 225
9.6 MIDDLE EAST & AFRICA 231
10 COMPETITIVE LANDSCAPE 238
10.1 OVERVIEW 238
10.2 MARKET SHARE ANALYSIS 240
10.3 COMPETITIVE SCENARIO 241
10.3.1 ACQUISITIONS 241
10.3.2 EXPANSIONS 242
10.3.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 242
10.3.4 SERVICES LAUNCHES 243
11 COMPANY PROFILES 244
(Business Overview, Services Offered, Recent Developments, SWOT Analysis, and MnM View)*
11.1 EUROFINS SCIENTIFIC 244
11.2 LABCORP 249
11.3 SGS 252
11.4 CHARLES RIVER 256
11.5 WUXI PHARMATECH 261
11.6 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD) 264
11.7 EXOVA 267
11.8 PACE ANALYTICAL 270
11.9 ENVIGO 273
11.10 INTERTEK 276
11.11 MPI RESEARCH 280
11.12 MERCK KGAA 282
11.13 SOURCE BIOSCIENCE 284
*Details on Business Overview, Services Offered, Recent Developments, SWOT Analysis, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX 286
12.1 INSIGHTS OF INDUSTRY EXPERTS 286
12.2 DISCUSSION GUIDE 287
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 293
12.4 AVAILABLE CUSTOMIZATIONS 295
12.5 RELATED REPORTS 295
12.6 AUTHOR DETAILS 296

LIST OF TABLES

TABLE 1 BIOLOGICS FACING PATENT EXPIRY IN THE US/EU 43
TABLE 2 DRIVERS: IMPACT ANALYSIS 45
TABLE 3 RESTRAINTS: MARKET IMPACT 46
TABLE 4 OPPORTUNITIES: MARKET IMPACT 47
TABLE 5 CHALLENGES: MARKET IMPACT 48
TABLE 6 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMP 51
TABLE 7 DEVELOPMENT OF GLP ACROSS COUNTRIES 52
TABLE 8 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES 53
TABLE 9 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES 53
TABLE 10 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 56
TABLE 11 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 56
TABLE 12 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 58
TABLE 13 BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 58
TABLE 14 CELL-BASED ASSAY SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 15 VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 60
TABLE 16 VIROLOGY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 17 IN VITRO ASSAY SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 18 IN VIVO ASSAY SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 63
TABLE 19 SPECIES-SPECIFIC VIRAL PCR ASSAY SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 64
TABLE 20 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 65
TABLE 21 BIOMARKER TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 66
TABLE 22 DISTRIBUTION OF NEW MOLECULAR ENTITIES, BY PHASE 67
TABLE 23 PHARMACOKINETIC TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 68
TABLE 24 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 69
TABLE 25 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 70
TABLE 26 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 71
TABLE 27 THERMAL ANALYSIS SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 28 IMAGE ANALYSIS SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 73
TABLE 29 SURFACE AREA ANALYSIS SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 74
TABLE 30 OTHER PHYSICAL CHARACTERIZATION ANALYSIS SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 31 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 76
TABLE 32 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 77
TABLE 33 EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 78
TABLE 34 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 79
TABLE 35 STABILITY INDICATING METHOD VALIDATION SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 80
TABLE 36 CLEANING VALIDATION METHOD DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 81
TABLE 37 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 82
TABLE 38 TECHNICAL CONSULTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 83
TABLE 39 OTHER METHOD VALIDATION SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 84
TABLE 40 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 85
TABLE 41 RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 86
TABLE 42 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 87
TABLE 43 HEAVY METAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 88
TABLE 44 CHARACTERISTICS OF MAJOR CCI TESTING METHODS 89
TABLE 45 CONTAINER TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 90
TABLE 46 KARL FISCHER ANALYSIS SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 91
TABLE 47 WET CHEMISTRY ANALYSIS SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 92
TABLE 48 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 93
TABLE 49 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 94
TABLE 50 BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 94
TABLE 51 EVOLUTION OF FDA GUIDELINES FOR DISSOLUTION TESTING 95
TABLE 52 DISSOLUTION TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 96
TABLE 53 ICH PERMITTED DAILY EXPOSURE FOR ELEMENTAL IMPURITIES 97
TABLE 54 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 98
TABLE 55 USP 32 DISINTEGRATION METHOD AND IMMERSION MEDIA INFORMATION 99
TABLE 56 DISINTEGRATION TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 99
TABLE 57 HARDNESS TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 100
TABLE 58 FRIABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 101
TABLE 59 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 102
TABLE 60 STABILITY TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 103
TABLE 61 STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 104
TABLE 62 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 105
TABLE 63 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 106
TABLE 64 ACCELERATED STABILITY STUDY CONDITION 107
TABLE 65 ACCELERATED STABILITY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 107
TABLE 66 PHOTOSTABILITY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 108
TABLE 67 COMPARATIVE STABILITY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 109
TABLE 68 OTHER STABILITY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 110
TABLE 69 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 111
TABLE 70 MICROBIAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 111
TABLE 71 STANDARD LIMIT FOR MICROBIAL LIMIT TESTING 112
TABLE 72 MICROBIAL LIMIT TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 113
TABLE 73 STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 114
TABLE 74 ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 115
TABLE 75 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 116
TABLE 76 STANDARDIZED LIMITS FOR WATER TESTING 117
TABLE 77 WATER TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 117
TABLE 78 OTHER MICROBIAL TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 118
TABLE 79 ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 119
TABLE 80 ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 119
TABLE 81 PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR 120
TABLE 82 AIR TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 121
TABLE 83 STANDARDS FOR WASTEWATER QUALITY 122
TABLE 84 WASTEWATER/ETP TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 122
TABLE 85 OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 123
TABLE 86 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 125
TABLE 87 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 128
TABLE 88 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 129
TABLE 89 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 130
TABLE 90 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 133
TABLE 91 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 135
TABLE 92 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 135
TABLE 93 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 136
TABLE 94 NORTH AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 136
TABLE 95 NORTH AMERICA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 137
TABLE 96 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 137
TABLE 97 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 138
TABLE 98 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 138
TABLE 99 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 139
TABLE 100 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 139
TABLE 101 NORTH AMERICA: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 140
TABLE 102 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2016–2023 (USD MILLION) 140
TABLE 103 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 142
TABLE 104 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 142
TABLE 105 US: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 143
TABLE 106 US: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 143
TABLE 107 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 144
TABLE 108 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 144
TABLE 109 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 145
TABLE 110 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 145
TABLE 111 US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 146
TABLE 112 US: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 146
TABLE 113 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 146
TABLE 114 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 147
TABLE 115 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 148
TABLE 116 CANADA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 148
TABLE 117 CANADA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 149
TABLE 118 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 149
TABLE 119 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 150
TABLE 120 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 150
TABLE 121 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 151
TABLE 122 CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 151
TABLE 123 CANADA: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 152
TABLE 124 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2016–2023 (USD MILLION) 152
TABLE 125 EUROPE: PHARMACEUTICAL R&D EXPENDITURE AND PRODUCTION, BY COUNTRY (2015) 153
TABLE 126 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 155
TABLE 127 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 155
TABLE 128 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 156
TABLE 129 EUROPE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 156
TABLE 130 EUROPE: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 157
TABLE 131 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 157
TABLE 132 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 158
TABLE 133 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 158
TABLE 134 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 159
TABLE 135 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 159
TABLE 136 EUROPE: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 160
TABLE 137 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 160
TABLE 138 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 162
TABLE 139 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 162
TABLE 140 GERMANY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 163
TABLE 141 GERMANY: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 163
TABLE 142 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 164
TABLE 143 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 164
TABLE 144 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 165
TABLE 145 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 165
TABLE 146 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 166
TABLE 147 GERMANY: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 166
TABLE 148 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2016–2023 (USD MILLION) 166
TABLE 149 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 168
TABLE 150 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2
016–2023 (USD MILLION) 168
TABLE 151 UK: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 169
TABLE 152 UK: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 169
TABLE 153 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 170
TABLE 154 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 170
TABLE 155 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 171
TABLE 156 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 171
TABLE 157 UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 172
TABLE 158 UK: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 172
TABLE 159 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 172
TABLE 160 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 173
TABLE 161 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 174
TABLE 162 FRANCE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 174
TABLE 163 FRANCE: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 175
TABLE 164 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 175
TABLE 165 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 176
TABLE 166 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 176
TABLE 167 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 177
TABLE 168 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 177
TABLE 169 FRANCE: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 178
TABLE 170 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 178
TABLE 171 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 172 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 173 ITALY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 174 ITALY: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 175 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 181
TABLE 176 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 181
TABLE 177 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 182
TABLE 178 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 182
TABLE 179 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 183
TABLE 180 ITALY: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 183
TABLE 181 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 183
TABLE 182 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 184
TABLE 183 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 185
TABLE 184 SWITZERLAND: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 185
TABLE 185 SWITZERLAND: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 186
TABLE 186 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 186
TABLE 187 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 187
TABLE 188 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 187
TABLE 189 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 188
TABLE 190 SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 188
TABLE 191 SWITZERLAND: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 189
TABLE 192 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2016–2023 (USD MILLION) 189
TABLE 193 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 190
TABLE 194 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 191
TABLE 195 ROE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 191
TABLE 196 ROE: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 192
TABLE 197 ROE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 192
TABLE 198 ROE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 193
TABLE 199 ROE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 193
TABLE 200 ROE: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 194
TABLE 201 ROE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 194
TABLE 202 ROE: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 195
TABLE 203 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 195
TABLE 204 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 196
TABLE 205 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 197
TABLE 206 APAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 197
TABLE 207 APAC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 198
TABLE 208 APAC: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 198
TABLE 209 APAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 199
TABLE 210 APAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 199
TABLE 211 APAC: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 200
TABLE 212 APAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 200
TABLE 213 APAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 201
TABLE 214 APAC: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 201
TABLE 215 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 201
TABLE 216 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 202
TABLE 217 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 203
TABLE 218 CHINA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 203
TABLE 219 CHINA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 204
TABLE 220 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 204
TABLE 221 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 205
TABLE 222 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 205
TABLE 223 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 206
TABLE 224 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 206
TABLE 225 CHINA: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 207
TABLE 226 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 207
TABLE 227 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 208
TABLE 228 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 209
TABLE 229 JAPAN: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 209
TABLE 230 JAPAN: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 210
TABLE 231 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 210
TABLE 232 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 211
TABLE 233 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 211
TABLE 234 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 212
TABLE 235 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 212
TABLE 236 JAPAN: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 213
TABLE 237 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 213
TABLE 238 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 214
TABLE 239 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 215
TABLE 240 INDIA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 215
TABLE 241 INDIA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 216
TABLE 242 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 216
TABLE 243 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 217
TABLE 244 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 217
TABLE 245 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 218
TABLE 246 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 218
TABLE 247 INDIA: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 219
TABLE 248 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 219
TABLE 249 ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 220
TABLE 250 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 221
TABLE 251 ROAPAC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 221
TABLE 252 ROAPAC: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 222
TABLE 253 ROAPAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 222
TABLE 254 ROAPAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 223
TABLE 255 ROAPAC: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 223
TABLE 256 ROAPAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 224
TABLE 257 ROAPAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 224
TABLE 258 ROAPAC: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 225
TABLE 259 ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 225
TABLE 260 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 226
TABLE 261 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 227
TABLE 262 LATIN AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 227
TABLE 263 LATIN AMERICA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 228
TABLE 264 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 228
TABLE 265 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 229
TABLE 266 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 229
TABLE 267 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 230
TABLE 268 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 230
TABLE 269 LATIN AMERICA: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 231
TABLE 270 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2016–2023 (USD MILLION) 231
TABLE 271 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 232
TABLE 272 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 233
TABLE 273 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 233
TABLE 274 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 234
TABLE 275 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 234
TABLE 276 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 235
TABLE 277 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 235
TABLE 278 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 236
TABLE 279 MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 236
TABLE 280 MIDDLE EAST & AFRICA: VIROLOGY TESTING SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 237
TABLE 281 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 237
TABLE 282 GROWTH STRATEGY MATRIX (2014–2017) 239
TABLE 283 ACQUISITIONS, 2014–2017 241
TABLE 284 EXPANSIONS, 2014–2017 242
TABLE 285 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2014–2017 242
TABLE 286 SERVICE LAUNCHES, 2014–2017 243


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 27
FIGURE 2 DATA TRIANGULATION METHODOLOGY 32
FIGURE 3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018 VS. 2023 (USD MILLION) 34
FIGURE 4 DISSOLUTION TESTING TO REGISTER HIGHEST GROWTH DURING THE
FORECAST PERIOD 35
FIGURE 5 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 36
FIGURE 6 GEOGRAPHIC SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 37
FIGURE 7 GROWING FOCUS ON ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS TO DRIVE THE GROWTH OF THE MARKET IN 2017 38
FIGURE 8 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT COMMANDED THE LARGEST MARKET SHARE IN 2017 39
FIGURE 9 INDIA AND CHINA TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD 40
FIGURE 10 APAC TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD 41
FIGURE 11 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
FIGURE 12 CONSOLIDATION AND LONG-TERM OUTSOURCING PARTNERSHIPS ARE LEADING INDUSTRY TRENDS 49
FIGURE 13 SERVICE SPONSOR OUTSOURCING RELATION TO TESTING VENDOR 50
FIGURE 14 BATCH-RELEASE TESTING SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 55
FIGURE 15 CELL-BASED ASSAYS WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET BY 2023 57
FIGURE 16 LASER PARTICLE SIZE ANALYSIS WILL CONTINUE TO DOMINATE THE PHYSICAL CHARACTERIZATION SERVICES MARKET DURING THE FORECAST PERIOD 69
FIGURE 17 US FDA DRUG RECALLS, BY CLASS AND YEAR (2010–2015) 85
FIGURE 18 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET IN 2023 125
FIGURE 19 R&D SPENDING OF PHRMA MEMBER COMPANIES, 1995–2015 126
FIGURE 20 BIOPHARMACEUTICAL PIPELINE, BY CATEGORY, 2016 127
FIGURE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC SNAPSHOT (2018–2023) 132
FIGURE 22 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT 134
FIGURE 23 PHARMACEUTICAL R&D EXPENDITURE IN THE US (2000–2015) 141
FIGURE 24 NUMBER OF FDA APPROVED MEDICINES, 2006–2015 141
FIGURE 25 NUMBER OF NEW CHEMICAL OR BIOLOGICAL ENTITIES (2002–2016) 153
FIGURE 26 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT 154
FIGURE 27 BIOTECHNOLOGY AND PHARMACEUTICAL PATENT APPLICATIONS IN EUROPE,
BY COUNTRY (2015) 161
FIGURE 28 ACQUISITION WAS THE MOST WIDELY ADOPTED GROWTH STRATEGY BY MARKET PLAYERS BETWEEN 2014 AND 2017 238
FIGURE 29 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 240
FIGURE 30 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2016) 244
FIGURE 31 LABCORP: COMPANY SNAPSHOT (2016) 249
FIGURE 32 SGS: COMPANY SNAPSHOT (2017) 252
FIGURE 33 CHARLES RIVER: COMPANY SNAPSHOT (2016) 256
FIGURE 34 EXOVA: COMPANY SNAPSHOT (2016) 267
FIGURE 35 INTERTEK: COMPANY SNAPSHOT (2016) 276
FIGURE 36 MERCK: COMPANY SNAPSHOT (2016) 282


【レポートのキーワード】

医療向け分析検査サービス

★調査レポート[医療向け分析検査サービスの世界市場予測(~2023年):種類、エンドユーザー、地域別分析] ( Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023 / AST-4341) 販売に関する免責事項
[医療向け分析検査サービスの世界市場予測(~2023年):種類、エンドユーザー、地域別分析] ( Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023 / AST-4341) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆